Cargando…

Screening Strategies for a Sustainable Endpoint for Gambiense Sleeping Sickness

BACKGROUND: Gambiense human African trypanosomiasis ([gHAT] sleeping sickness) is a vector-borne disease that is typically fatal without treatment. Intensified, mainly medical-based, interventions in endemic areas have reduced the occurrence of gHAT to historically low levels. However, persistent re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castaño, M Soledad, Aliee, Maryam, Mwamba Miaka, Erick, Keeling, Matt J, Chitnis, Nakul, Rock, Kat S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289553/ https://www.ncbi.nlm.nih.gov/pubmed/31876949 http://dx.doi.org/10.1093/infdis/jiz588

Ejemplares similares

Modelling to Quantify the Likelihood that Local Elimination of Transmission has Occurred Using Routine Gambiense Human African Trypanosomiasis Surveillance Data
por: Davis, Christopher N, et al.
Publicado: (2021)

Predicting the impact of COVID-19 interruptions on transmission of gambiense human African trypanosomiasis in two health zones of the Democratic Republic of Congo
por: Aliee, Maryam, et al.
Publicado: (2021)

Assessing Strategies Against Gambiense Sleeping Sickness Through Mathematical Modeling
por: Rock, Kat S, et al.
Publicado: (2018)

Identifying regions for enhanced control of gambiense sleeping sickness in the Democratic Republic of Congo
por: Huang, Ching-I, et al.
Publicado: (2022)

Village-scale persistence and elimination of gambiense human African trypanosomiasis
por: Davis, Christopher N., et al.
Publicado: (2019)

Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo
por: Davis, Christopher N., et al.
Publicado: (2021)

Modelling to explore the potential impact of asymptomatic human infections on transmission and dynamics of African sleeping sickness
por: Aliee, Maryam, et al.
Publicado: (2021)

Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo
por: Crump, Ronald E., et al.
Publicado: (2021)

Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo
por: Antillon, Marina, et al.
Publicado: (2022)

Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC
por: Crump, Ronald E., et al.
Publicado: (2022)

Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination?
por: Büscher, Philippe, et al.
Publicado: (2018)

A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC
por: Huang, Ching-I, et al.
Publicado: (2023)

Estimating the distribution of time to extinction of infectious diseases in mean-field approaches
por: Aliee, Maryam, et al.
Publicado: (2020)

Assessing the impact of aggregating disease stage data in model predictions of human African trypanosomiasis transmission and control activities in Bandundu province (DRC)
por: Castaño, María Soledad, et al.
Publicado: (2020)

Modelling gambiense human African trypanosomiasis infection in villages of the Democratic Republic of Congo using Kolmogorov forward equations
por: Davis, Christopher N., et al.
Publicado: (2021)

Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo
por: Rock, Kat S., et al.
Publicado: (2017)

The Natural Progression of Gambiense Sleeping Sickness: What Is the Evidence?
por: Checchi, Francesco, et al.
Publicado: (2008)

Estimates of the duration of the early and late stage of gambiense sleeping sickness
por: Checchi, Francesco, et al.
Publicado: (2008)

Implications of Heterogeneous Biting Exposure and Animal Hosts on Trypanosomiasis brucei gambiense Transmission and Control
por: Stone, Chris M., et al.
Publicado: (2015)

Performance of Parasitological and Molecular Techniques for the Diagnosis and Surveillance of Gambiense Sleeping Sickness
por: Mumba Ngoyi, Dieudonné, et al.
Publicado: (2014)

Passive Screening and Diagnosis of Sleeping Sickness with New Tools in Primary Health Services: An Operational Research
por: Mulenga, Philippe, et al.
Publicado: (2019)

The effect of livestock density on Trypanosoma brucei gambiense and T. b. rhodesiense: A causal inference-based approach
por: Meisner, Julianne, et al.
Publicado: (2022)

Accuracy of Individual Rapid Tests for Serodiagnosis of Gambiense Sleeping Sickness in West Africa
por: Jamonneau, Vincent, et al.
Publicado: (2015)

Specificity of malaria rapid diagnostic tests is affected by Trypanosoma brucei gambiense sleeping sickness
por: Gillet, Philippe, et al.
Publicado: (2012)

Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo
por: Das, Aatreyee M., et al.
Publicado: (2021)

NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping Sickness
por: Yun, Oliver, et al.
Publicado: (2010)

Cerebrospinal Fluid Neopterin as Marker of the Meningo-Encephalitic Stage of Trypanosoma brucei gambiense Sleeping Sickness
por: Tiberti, Natalia, et al.
Publicado: (2012)

Recombinant Antigens Expressed in Pichia pastoris for the Diagnosis of Sleeping Sickness Caused by Trypanosoma brucei gambiense
por: Rogé, Stijn, et al.
Publicado: (2014)

Isolation of Trypanosoma brucei gambiense from Cured and Relapsed Sleeping Sickness Patients and Adaptation to Laboratory Mice
por: Pyana, Patient Pati, et al.
Publicado: (2011)

In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness
por: Schmid, Caecilia, et al.
Publicado: (2012)

Silent Human Trypanosoma brucei gambiense Infections around the Old Gboko Sleeping Sickness Focus in Nigeria
por: Solomon Ngutor, Karshima, et al.
Publicado: (2016)

Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection
por: Ngay Lukusa, Ipos, et al.
Publicado: (2021)

Nutrient reference value: non-communicable disease endpoints—a conference report
por: Lupton, J. R., et al.
Publicado: (2016)

Three Drug Combinations for Late-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Uganda
por: Priotto, Gerardo, et al.
Publicado: (2006)

Neopterin Is a Cerebrospinal Fluid Marker for Treatment Outcome Evaluation in Patients Affected by Trypanosoma brucei gambiense Sleeping Sickness
por: Tiberti, Natalia, et al.
Publicado: (2013)

Neopterin and CXCL-13 in Diagnosis and Follow-Up of Trypanosoma brucei gambiense Sleeping Sickness: Lessons from the Field in Angola
por: Bonnet, Julien, et al.
Publicado: (2019)

Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d’Ivoire using an integrated approach
por: Kaba, Dramane, et al.
Publicado: (2023)

Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study
por: Ngay Lukusa, Ipos, et al.
Publicado: (2022)

Costs Of Using “Tiny Targets” to Control Glossina fuscipes fuscipes, a Vector of Gambiense Sleeping Sickness in Arua District of Uganda
por: Shaw, Alexandra P. M., et al.
Publicado: (2015)

Whose Elimination? Frontline Workers’ Perspectives on the Elimination of the Human African Trypanosomiasis and Its Anticipated Consequences
por: Falisse, Jean-Benoît, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oh4b11o1trjcolvvj8j01lvdjm